Parkinson disease 22, autosomal dominant
MONDO:0014742Any Parkinson disease in which the cause of the disease is a mutation in the CHCHD2 gene.
Also known as: CHCHD2 Parkinson disease, PARK22, Parkinson disease 22, autosomal dominant, Parkinson disease 22, autosomal dominant; PARK22, Parkinson disease caused by mutation in CHCHD2
11 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can a One-Time bone drug shield Parkinson's patients from fractures?
Prevention CompletedThis study tested whether a single infusion of zoledronic acid (Reclast) can prevent fractures in men and women aged 60 and older with Parkinson's disease or related conditions. Over 2,700 participants were randomly assigned to receive either the drug or a placebo, and were follo…
Phase: PHASE4 • Sponsor: California Pacific Medical Center Research Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Bubble therapy shows promise for Parkinson's symptoms
Symptom relief CompletedThis study tested whether infusing tiny bubbles of oxyhydrogen gas could help people with Parkinsonism. 35 adults received the infusion alongside their usual care. Researchers measured changes in disease severity, thinking ability, and quality of life. The goal was to see if this…
Phase: PHASE2, PHASE3 • Sponsor: dr. Siti Nurlaela, SpN • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Parkinson's Patients' hospital stays under the microscope
Knowledge-focused CompletedThis completed study looked at over 2,500 people with Parkinson's disease who were admitted to the hospital through the emergency room. Researchers wanted to find the main reasons for these hospital stays and compare them to people of the same age without Parkinson's. The goal wa…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC